Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q4 2024 Earnings

31OctConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-21.46

-15.12

-8.79

-2.46

Details

Expected EPS

-18.3782796873

Actual EPS

-17.443413

Surprise EPS

0.93

Surprise Percent

+5.09%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -17.443413 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.